Market Place
Sourcing Support
Covis Announces Completion of Announced Financial Recapitalization Transaction
01 Jun 2023 //
GLOBENEWSWIRE
Covis Statement on FDA Decision to Withdraw Approval of Makena®
07 Apr 2023 //
GLOBENEWSWIRE
US FDA withdraws approval for Covis Pharma`s preterm birth prevention drug
07 Apr 2023 //
REUTERS
Covis Announces Signing of Support Agreements With Lenders and Equity Sponsors
03 Apr 2023 //
GLOBENEWSWIRE
Controversial drug for preterm birth to be withdrawn, maker says
09 Mar 2023 //
BIOPHARMADIVE
Covis Responds to Presiding Officer Report Summarizing FDA Hearing
07 Mar 2023 //
GLOBENEWSWIRE
Covis Announces Positive Topline Results from the AVANT Phase 3 Clinical Trial
25 Oct 2022 //
GLOBENEWSWIRE
An FDA advisory committee voted to pull Covis` drug from market
20 Oct 2022 //
FIERCEPHARMA
FDA staffers urge withdrawal of Covis` Makena
18 Oct 2022 //
FIERCEPHARMA
FDA releases docs on controversial preterm birth med Makena ahead of adcomm
08 Oct 2022 //
ENDPTS
Voting questions set for premature birth drug`s withdrawal hearing
16 Aug 2022 //
ENDPTS
Covis Pharma Group Announces Executive Leadership Appointment in Canada
14 Jul 2022 //
GLOBENEWSWIRE
Covis Pharma gets long-awaited FDA hearing date
16 Jun 2022 //
FIERCEPHARMA
Covis Pharma Provides Update on FDA Public Hearing for Makena
14 Jun 2022 //
GLOBENEWSWIRE
Ahead of accelerated approval withdrawal, Covis asks FDA to omit study
11 Jun 2022 //
ENDPTS
Premature birth drug saga drags on as Covis questions fairness of FDA hearing
10 Feb 2022 //
ENDPTS
Covis Pharma Group Announces Two Executive Management Team Appointments
31 Jan 2022 //
GLOBENEWSWIRE
AZN completes transfer of global rights to Eklira & Duaklir to Covis Pharma
06 Jan 2022 //
PHARMABIZ
Covis Enters Promotion and Distribution Agreement for Two Respiratory Medicines
04 Jan 2022 //
GLOBENEWSWIRE
Covis Pharma Group Announces Two Executive Management Team Appointments
07 Dec 2021 //
GLOBENEWSWIRE
AstraZeneca sells 2 COPD inhalers to familiar face
02 Nov 2021 //
FIERCEPHARMA
Covis granted FDA hearing over premature-birth med Makena
21 Aug 2021 //
FIERCEPHARMA
FDA to Grant Public Hearing for FDA-Approved Treatment to Reduce Preterm Birth
19 Aug 2021 //
GLOBENEWSWIRE
COVIS PHARMA GROUP Announces Top-line Safety and Efficacy Data from a Phase 3
16 Apr 2021 //
GLOBENEWSWIRE
Asthma treatment fails Phase III test in COVID-19
15 Apr 2021 //
NEUROOTHERS
EPPPIC Study Reaffirms 17-OHPC for Reducing Early Preterm Birth in High-Risk
29 Mar 2021 //
PRESS RELEASE
Covis Group Completes Acquisition of AMAG Pharmaceuticals
16 Nov 2020 //
PRNEWSWIRE
Covis Group Completes Acquisition of AMAG Pharmaceuticals
16 Nov 2020 //
BIOSPACE
Covis Group to acquire AMAG Pharmaceuticals in $647m deal
05 Oct 2020 //
PHARMAFILE
Covis Group to acquire AMAG Pharmaceuticals in $647m deal
05 Oct 2020 //
PHARMAFILE
Covis Group Announces Agreement to Acquire AMAG Pharmaceuticals
01 Oct 2020 //
GLOBENEWSWIRE
Covis Pharma B.V. Initiates Ph3 Clinical Trial of Alvesco Inhaler for COVID-19
20 May 2020 //
PR NEWSWIRE
Covis Pharma taps Verify ahead of the extended DSCSA mandate
20 Jul 2017 //
OUTSOURCING
Impax Searches for a New CEO
21 Dec 2016 //
THE STREET
DOJ`s price-fixing investigation could lead to sizable liabilities, analyst says
10 Nov 2016 //
FIERCE PHARMA
U.S. Charges in Generic-Drug Probe to Be Filed by Year-End
04 Nov 2016 //
BLOOMBERG
Valeant Clone Concordia Top Canada Stock as CEO Eyes Deal
07 Apr 2015 //
BLOOMBERG BUSINESS
Concordia Healthcare to Buy Some Assets of Covis Pharma for $1.2 Billion
10 Mar 2015 //
REUTERS
